Page last updated: 2024-09-03

omega-n-methylarginine and Ductus Arteriosus, Patent

omega-n-methylarginine has been researched along with Ductus Arteriosus, Patent in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Black, MJ; Clyman, RI; Gubhaju, L; McCurnin, D; Seidner, S; Sutherland, MR; Yoder, BA1
Aranda, JV; Clyman, RI; Fields, S; Keller, RL; Ofenstein, JP; Tacy, TA1

Trials

1 trial(s) available for omega-n-methylarginine and Ductus Arteriosus, Patent

ArticleYear
Combined treatment with a nonselective nitric oxide synthase inhibitor (l-NMMA) and indomethacin increases ductus constriction in extremely premature newborns.
    Pediatric research, 2005, Volume: 58, Issue:6

    Topics: Drug Therapy, Combination; Ductus Arteriosus; Ductus Arteriosus, Patent; Enzyme Inhibitors; Female; Humans; Indomethacin; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Nitric Oxide Synthase; omega-N-Methylarginine

2005

Other Studies

1 other study(ies) available for omega-n-methylarginine and Ductus Arteriosus, Patent

ArticleYear
Effects of ibuprofen treatment on the developing preterm baboon kidney.
    American journal of physiology. Renal physiology, 2012, May-15, Volume: 302, Issue:10

    Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Body Weight; Drinking; Drug Interactions; Ductus Arteriosus, Patent; Enzyme Inhibitors; Female; Ibuprofen; Kidney; Kidney Glomerulus; Nephrons; Nitric Oxide Synthase; omega-N-Methylarginine; Organ Size; Papio; Pregnancy; Premature Birth; Urine

2012